Core Viewpoint - Rosen Law Firm is encouraging investors of Perrigo Company plc to secure legal counsel before the January 16, 2026 deadline for a securities class action lawsuit related to the company's performance during the specified class period [2][3]. Group 1: Class Action Details - The class period for the securities class action is from February 27, 2023, to November 4, 2025, inclusive [2]. - Investors who purchased Perrigo securities during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - A class action lawsuit has already been filed, and interested parties must move the court to serve as lead plaintiff by January 16, 2026 [4]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [5]. - The firm has a history of significant recoveries for investors, including over $438 million in 2019 alone, and has been recognized for its success in securities class action settlements [5]. Group 3: Case Allegations - The lawsuit alleges that Perrigo made materially false and misleading statements regarding its infant formula business, including issues related to underinvestment, necessary capital expenditures, and manufacturing deficiencies [6]. - As a result of these misstatements, Perrigo's financial results were overstated, leading to investor damages when the true information became public [6].

Group 1 - Robert F. Abbott has been managing family investments since 1995 and incorporated options trading in 2010, focusing on covered calls and collars with long stocks [1] - Abbott is a freelance writer with a project aimed at providing information for new and intermediate-level mutual fund investors [1] - He holds a Bachelor of Arts and a Master of Business Administration (MBA) degree [1]

Core Viewpoint - Rosen Law Firm is urging investors of Marex Group plc to secure legal counsel before the December 8, 2025 deadline for a securities class action related to misleading statements made during the Class Period from May 16, 2024, to August 5, 2025 [1][5]. Group 1: Legal Action Details - Investors who purchased Marex securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To participate in the class action, investors must act before the December 8, 2025 deadline to serve as lead plaintiff, which involves directing the litigation on behalf of other class members [3][7]. - The lawsuit alleges that Marex made materially false and misleading statements, including selling over-the-counter financial instruments to itself and inconsistencies in financial statements, leading to investor damages when the truth was revealed [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been ranked No. 1 for securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions of dollars for investors [4].

Core Viewpoint - The Rosen Law Firm is encouraging investors of DexCom, Inc. to secure legal counsel before the December 29, 2025 deadline for a securities class action related to misleading statements made by the company during the class period from July 26, 2024, to September 17, 2025 [1][2]. Summary by Sections Class Action Details - Investors who purchased DexCom securities during the specified class period may be eligible for compensation without incurring out-of-pocket fees through a contingency fee arrangement [2]. - To participate in the class action, investors must act before the lead plaintiff deadline of December 29, 2025 [3]. Legal Representation - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting their own success in recovering significant amounts for investors [4]. Allegations Against DexCom - The lawsuit alleges that DexCom made unauthorized design changes to its G6 and G7 continuous glucose monitoring systems, which compromised their reliability and posed health risks to users [5]. - It is claimed that DexCom downplayed the severity of these issues, leading to increased regulatory scrutiny and potential legal repercussions [5].

Core Viewpoint - Rosen Law Firm is urging investors of Cepton, Inc. to secure legal counsel before the December 8, 2025 deadline for a securities class action related to misleading statements made by the company during the class period from July 29, 2024, to January 6, 2025 [1][5]. Group 1: Legal Action Details - Investors who purchased or sold Cepton common stock during the specified class period may be eligible for compensation without incurring out-of-pocket fees through a contingency fee arrangement [2]. - To participate in the class action, investors must act before the December 8, 2025 deadline to serve as lead plaintiff, which involves directing the litigation on behalf of other class members [3][6]. - The lawsuit alleges that Cepton's management made materially false and misleading statements regarding the company's business and operations, including failing to disclose a credible third-party bid that valued Cepton at more than double the Koito Acquisition [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success in achieving significant settlements for investors [4]. - The firm has been recognized for its performance in securities class action settlements, including being ranked No. 1 by ISS Securities Class Action Services in 2017 and recovering over $438 million for investors in 2019 [4].

Core Viewpoint - Rosen Law Firm is reminding purchasers of WPP plc American Depositary Shares (ADS) about the upcoming lead plaintiff deadline for a class action lawsuit related to misleading statements made by the company during a specified period [1][5]. Group 1: Class Action Details - The class period for the lawsuit is from February 27, 2025, to July 8, 2025, and the lead plaintiff deadline is December 8, 2025 [1]. - Investors who purchased WPP ADSs during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a successful track record in securities class actions, as many firms may not have the necessary experience or resources [4]. - The Rosen Law Firm has a history of significant recoveries for investors, including over $438 million in 2019 alone, and has been recognized for its performance in securities class action settlements [4]. Group 3: Allegations Against WPP - The complaint alleges that WPP provided overly positive statements while concealing material adverse facts about its media arm's ability to handle macroeconomic challenges, leading to a loss of market share [5].

Core Insights - Alphabet Inc. (GOOG, GOOGL) has been experiencing strong momentum with a series of positive developments over recent months [1] Company Overview - The company is viewed favorably by shareholders, with one individual noting an average entry price of $185 per share [1] - The focus is on identifying GARP (Growth At a Reasonable Price) and turnaround stocks, emphasizing the importance of valuation in stock selection [1] Investment Strategy - The investment strategy is centered around stocks that present limited downside risk and significant upside potential [1] - The portfolio manager has a background in business studies across multiple countries, indicating a diverse educational foundation [1] Market Position - The company is highlighted as a popular choice among investors, with the portfolio manager being recognized as a Popular Investor on the eToro platform [1]

Core Insights - Alphabet Inc. (GOOG, GOOGL) has experienced significant positive momentum recently, driven by a series of favorable developments [1] Group 1: Company Performance - The company has been highlighted as a potential GARP (Growth At a Reasonable Price) investment, indicating a focus on stocks that offer growth potential without excessive valuation [1] - The average entry price for shareholders is noted at $185 per share, suggesting a strong interest in maintaining a favorable investment position [1] Group 2: Analyst Background - The article is authored by a professional portfolio manager with extensive experience in investment funds, indicating a level of expertise in stock analysis [1] - The author has a publicly available portfolio on eToro, showcasing transparency in investment opinions and decisions [1]

MOH DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Molina Healthcare, Inc. Investors to Secure Counsel Before Important December 2 Deadline in Securities Class Action - MOHNovember 29, 2025 10:21 PM EST | Source: The Rosen Law Firm PANew York, New York--(Newsfile Corp. - November 29, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Molina Healthcare, Inc. (NYSE: MOH) between February 5, 2025 and July 23, 2025, both dates inclusive (t ...

Xreal One Pro ZDNET's key takeaways The Xreal One Pro is available for $599 for a limited time. Thanks to the X1 chip, no special software is required for advanced functionality, the FOV is the best available, the glasses are comfortable, and the display is bright and clear. The glasses are rather expensive, and two sizes for your eye width make them fit best for individuals.$599 at AmazonFollow ZDNET: Add us as a preferred source on Google.For the past several months, I have been wearing the Xreal One ...